|
|
|
Volumn 25, Issue 10, 2011, Pages
|
|
FDA approves brentuximab vedotin for hodgkin lymphoma and systemic anaplastic large-cell lymphoma
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRENTUXIMAB VEDOTIN;
CD30 ANTIGEN;
APOPTOSIS;
ASPIRATION BIOPSY;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CANCER GROWTH;
CANCER REGRESSION;
CANCER RELAPSE;
CELL DEATH;
DIARRHEA;
DRUG APPROVAL;
DRUG FEVER;
DRUG RESPONSE;
DRUG TOLERABILITY;
FATIGUE;
FOOD AND DRUG ADMINISTRATION;
HODGKIN DISEASE;
HUMAN;
LARGE CELL LYMPHOMA;
LYMPH NODE BIOPSY;
MAXIMUM TOLERATED DOSE;
NAUSEA;
NEUTROPENIA;
NOTE;
OPTIMAL DRUG DOSE;
PERIPHERAL NEUROPATHY;
REED STERNBERG CELL;
THROMBOCYTOPENIA;
UPPER RESPIRATORY TRACT INFECTION;
|
|
EID: 80053928968
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
